{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:47:46Z","timestamp":1790736466916,"version":"4.1.0"},"reference-count":48,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Atopic dermatitis (AD) is a chronic recurrent inflammatory skin disease with a bipolar age distribution in childhood, adolescence and middle adulthood. Up to 50% of AD patients show ocular involvement, which can be potentially sight threatening. Clinically, the majority of cases present with atopic blepharo(kerato)conjunctivitis or atopic keratoconjunctivitis (AKC); other clinical variants from this group of inflammatory ocular surface diseases are keratoconjunctivitis vernalis in childhood and adolescence and allergic conjunctivitis. In addition to the aforementioned blepharitis, keratitis and conjunctivitis, AD is also associated with eyelid involvement with subsequent eyelid malposition, limbal insufficiency with the development of pseudopterygia, (chronic) cicatrizing conjunctivitis with symblephara formation and fornix shortening, as well as ocular surface malignancies such as conjunctival intraepithelial neoplasia (CIN) and squamous cell carcinoma. In addition, an\n          association with AD or AKC has been described for keratoconus. Whereas the therapy of AD in dermatology has made revolutionary advances in recent years through the use of biologicals, the primary use of these biologicals in ophthalmological complications is still very hesitant. Treatment here is often provided using topical steroids and calcineurin inhibitors. The following article summarises recent developments in basic and clinical dermatological research and discusses them in the context of current concepts for ophthalmological therapy.<\/jats:p>","DOI":"10.1055\/a-2244-2885","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T19:00:02Z","timestamp":1712862002000},"page":"607-618","source":"Crossref","is-referenced-by-count":4,"title":["Atopic Keratoconjunctivitis: Pathophysiology, Clinic, and Potential New Therapeutic Concepts"],"prefix":"10.1055","volume":"241","author":[{"given":"Thabo","family":"Lapp","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Augenheilkunde, Universit\u00e4tsklinikum Freiburg, Deutschland"},{"name":"Augenzentrum am St. Franziskus Hospital, M\u00fcnster, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mann","sequence":"additional","affiliation":[{"name":"Haut- und Poliklinik, Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Jakob","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Dermatologie und Allergologie, Universit\u00e4tsklinikum Gie\u00dfen und Marburg, Gie\u00dfen, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reinhard","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Augenheilkunde, Universit\u00e4tsklinikum Freiburg, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Christian","family":"Maier","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Augenheilkunde, Universit\u00e4tsklinikum Freiburg, Deutschland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,4,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41423-023-00992-4","article-title":"The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment","volume":"20","author":"P Facheris","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s00347-017-0473-3","article-title":"[Ocular involvement in atopic dermatitis: Clinical aspects and therapy]","volume":"114","author":"P Maier","year":"2017","journal-title":"Ophthalmologe"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.alit.2021.07.003","article-title":"Subtypes of atopic dermatitis: From phenotype to endotype","volume":"71","author":"Y Tokura","year":"2022","journal-title":"Allergol Int"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jaci.2011.01.053","article-title":"Contrasting pathogenesis of atopic dermatitis and psoriasis\u2013part I: clinical and pathologic concepts","volume":"127","author":"E Guttman-Yassky","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra2023911","article-title":"Atopic Dermatitis","volume":"384","author":"S St\u00e4nder","year":"2021","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"S M Langan","year":"2020","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40272-022-00499-x","article-title":"Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting","volume":"24","author":"L F Eichenfield","year":"2022","journal-title":"Paediatr Drugs"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/j.ophtha.2012.03.045","article-title":"Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up","volume":"119","author":"M Krilis","year":"2012","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00347-017-0483-1","article-title":"[Pathophysiology of atopic blepharokeratoconjunctivitis]","volume":"114","author":"T Lapp","year":"2017","journal-title":"Ophthalmologe"},{"key":"ref10","first-page":"189","article-title":"Ocular complications of atopic dermatitis","volume":"104","author":"J I Hsu","year":"2019","journal-title":"Cutis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jaad.2020.11.037","article-title":"Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: A systematic review and meta-analysis","volume":"85","author":"N H Ravn","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.anai.2019.04.020","article-title":"Comorbidities and the impact of atopic dermatitis","volume":"123","author":"J I Silverberg","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2310\/6620.2007.06034","article-title":"A population-based survey of eczema prevalence in the United States","volume":"18","author":"J M Hanifin","year":"2007","journal-title":"Dermatitis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.jaad.2018.05.1241","article-title":"A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis","volume":"80","author":"H H Lee","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.sder.2012.07.006","article-title":"Understanding and managing atopic dermatitis in adult patients","volume":"31","author":"C N Ellis","year":"2012","journal-title":"Semin Cutan Med Surg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"adv00160","DOI":"10.2340\/00015555-3510","article-title":"Prevalence and Incidence of Atopic Dermatitis: A Systematic Review","volume":"100","author":"S Bylund","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0161-6420(98)94017-9","article-title":"Long-term follow-up of patients with atopic keratoconjunctivitis","volume":"105","author":"W J Power","year":"1998","journal-title":"Ophthalmology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jaci.2010.06.050","article-title":"The epidemiology of ocular and nasal allergy in the United States, 1988\u20131994","volume":"126","author":"K Singh","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/pai.13035","article-title":"Diagnosing and managing allergic conjunctivitis in childhood: The allergist\u02bcs perspective","volume":"30","author":"J L Fauquert","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1136\/bjo.2007.117812","article-title":"Prevalence of vernal keratoconjunctivitis: a rare disease?","volume":"92","author":"D Bremond-Gignac","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/jid.2011.393","article-title":"One remarkable molecule: filaggrin","volume":"132","author":"S J Brown","year":"2012","journal-title":"J Invest Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1398-9995.2010.02464.x","article-title":"Determinants of eczema: population-based cross-sectional study in Germany","volume":"66","author":"C J Apfelbacher","year":"2011","journal-title":"Allergy"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2500\/aap2007.28.3041","article-title":"Importance of genetic factors in the etiology of atopic dermatitis: a twin study","volume":"28","author":"S F Thomsen","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/ng.3424","article-title":"Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis","volume":"47","author":"L Paternoster","year":"2015","journal-title":"Nat Genet"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"C NA Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jaci.2009.03.036","article-title":"Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease","volume":"123","author":"E Rodr\u00edguez","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMra1011040","article-title":"Filaggrin mutations associated with skin and allergic diseases","volume":"365","author":"A D Irvine","year":"2011","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jaci.2011.01.031","article-title":"Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy","volume":"127","author":"S J Brown","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000355965","article-title":"Analysis of filaggrin mutations and expression in corneal specimens from patients with or without atopic dermatitis","volume":"163","author":"T Lapp","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1016\/j.jaci.2009.07.012","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"124","author":"M D Howell","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"M Salimi","year":"2013","journal-title":"J Exp Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.alit.2022.09.005","article-title":"Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eye","volume":"72","author":"K Fukuda","year":"2023","journal-title":"Allergol Int"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2133.1974.tb06447.x","article-title":"Staphylococcus aureus in the lesions of atopic dermatitis","volume":"90","author":"J J Leyden","year":"1974","journal-title":"Br J Dermatol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","author":"H H Kong","year":"2012","journal-title":"Genome Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd4624","article-title":"Targeting key proximal drivers of type 2 inflammation in disease","volume":"15","author":"N A Gandhi","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jaci.2014.08.001","article-title":"Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis","volume":"134","author":"K Yoshida","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e0156077","DOI":"10.1371\/journal.pone.0156077","article-title":"IgE Sensitization Profiles Differ between Adult Patients with Severe and Moderate Atopic Dermatitis","volume":"11","author":"I Mittermann","year":"2016","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/ACI.0000000000000471","article-title":"Ocular allergy as a risk factor for dry eye in adults and children","volume":"18","author":"E Villani","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"09","key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009078.pub2","article-title":"Topical cyclosporine for atopic keratoconjunctivitis","author":"J J Gonz\u00e1lez-L\u00f3pez","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13167-016-0065-3","article-title":"Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine","volume":"7","author":"S Hagan","year":"2016","journal-title":"EPMA J"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1097\/ICL.0000000000000688","article-title":"Potential Biomarkers for Allergic Conjunctival Diseases","volume":"46","author":"N Roy","year":"2020","journal-title":"Eye Contact Lens"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2324400","DOI":"10.1155\/2021\/2324400","article-title":"Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review","volume":"2021","author":"J Wen","year":"2021","journal-title":"J Immunol Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/ced.14651","article-title":"Successful treatment of severe blepharitis in a patient with atopic dermatitis by topical delgocitinib","volume":"46","author":"T Dainichi","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1136\/bjophthalmol-2019-315010","article-title":"Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment","volume":"104","author":"Y Nahum","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"110286","DOI":"10.1016\/j.ygeno.2022.110286","article-title":"The Human Eye Transcriptome Atlas: A searchable comparative transcriptome database for healthy and diseased human eye tissue","volume":"114","author":"J Wolf","year":"2022","journal-title":"Genomics"},{"issue":"S 1","key":"ref46","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1007\/s00347-022-01721-4","article-title":"Web-based gene expression analysis-paving the way to decode healthy and diseased ocular tissue","volume":"120","author":"J Wolf","year":"2023","journal-title":"Ophthalmologie"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00105-018-4316-1","article-title":"[Interdisciplinary recommendations for action in dupilumab-related inflammatory eye diseases]","volume":"70","author":"J Wohlrab","year":"2019","journal-title":"Hautarzt"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/all.15174","article-title":"Epithelial barrier dysfunction in ocular allergy","volume":"77","author":"N Singh","year":"2022","journal-title":"Allergy"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2244-2885.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T23:33:12Z","timestamp":1759361592000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2244-2885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,11]]},"references-count":48,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2024,5,22]]},"published-print":{"date-parts":[[2024,5]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2244-2885","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,11]]}}}